The European MH Group: Protocol for in Vitro Diagnosis of Susceptibility to MH and Preliminary Results
Lack of International agreement on standard test procedures for the diagnosis of malignant hyperthermia susceptibility led to the formation of the European MH Group in 1983. Our group now comprises twelve countries with eighteen test centres meeting regularly. This paper outlines our protocol, specifying how the halothane and the caffeine tests are performed by members of the European MH Group, and compares results obtained in different MH centres.
KeywordsDioxide Caffeine Halothane Ster
Unable to display preview. Download preview PDF.
- 3.Ellis, F.R., Harriman, D.G.F., Currie, S. and Cain, P. In: Aldrete, J.A. and Britt, B.A. (eds.). Second International Symposium on Malignant Hyperthermia. 1978. New York: Grune and Stratton, pp. 273–85.Google Scholar
- 5.Ording, H. and Skovgaard, L.T. Acta Anaesthesiol. Scand (in press, 1987).Google Scholar
- 6.European MH Group. Br. J. Anaesth. 1985;57:1038.Google Scholar